9:25 am

Relabeling of Existing Drugs

William Rodriguez, PhD, MD

U.S. Food and Drug Administration

9:40 am

Lessons Learned and Future Directions

Dianne Murphy, MD

U.S. Food and Drug Administration

9:55 am

Discussion

10:25 am

Break

Incentives and Disincentives for Pediatric Drug Development

10:40 am

Ethical Issues Concerning Testing of New Drugs in Children

Robert Nelson, MD, PhD

Children’s Hospital of Philadelphia

10:55 am

Natasha Jarrett

Hoffmann-LaRoche

11:10 am

Thomas Hassall, RPh, MS

Abbott Laboratories

11:25 am

Discussion

12:00 pm

Lunch

Dose Finding and Bioavailability Guessing

1:00 pm

Robert Ward, MD

University of Utah

1:15 pm

Best Pharmaceuticals for Children Act: Pediatric Formulation Issues

George Giacoia, MD

National Institute of Child Health and Human Development, National Institutes of Health

1:30 pm

Discussion



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement